Answers are grounded in this paper and cite their sources.
Review discusses mouse models quantifying alloantigen presentation in hematopoietic stem cell transplantation, indicating potential for improved therapies.
Allogeneic stem cell transplantation (alloSCT) is a curative therapy for hematopoietic malignancies. The therapeutic effect relies on donor T cells and NK cells to recognize and eliminate malignant cells, known as the graft-versus-leukemia (GVL) effect. However, off target immune pathology, known as graft-versus-host disease (GVHD) remains a major complication of alloSCT that limits the broad application of this therapy. The presentation of recipient-origin alloantigen to donor T cells is the primary process initiating GVHD and GVL. Therefore, the understanding of spatial and temporal characteristics of alloantigen presentation is pivotal to attempts to separate beneficial GVL effects from detrimental GVHD. In this review, we discuss mouse models and the tools therein, that permit the quantification of alloantigen presentation after alloSCT.
No takes yet. Share an insight, caveat, or question.
Koyama et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: